Search

Your search keyword '"Leblanc, Catherine"' showing total 294 results

Search Constraints

Start Over You searched for: Author "Leblanc, Catherine" Remove constraint Author: "Leblanc, Catherine" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
294 results on '"Leblanc, Catherine"'

Search Results

1. Plant and algal lipidomes: Analysis, composition, and their societal significance

3. A community perspective on the concept of marine holobionts: state-of-the-art, challenges, and future directions

6. Progress and future directions for seaweed holobiont research.

9. Evolutionary genomics of the emergence of brown algae as key components of coastal ecosystems

10. The genome of Ectocarpus subulatus – A highly stress-tolerant brown alga

12. Evolutionary genomics of the emergence of brown algae as key components of coastal ecosystems

18. Corrigendum: Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes

19. Aldehyde perception induces specific molecular responses in Laminaria digitata and affects algal consumption by a specialist grazer

23. Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes

24. Data from Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12C

25. Supplementary Data from Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12C

26. Supplementary Table S4 from FGF401, A First-In-Class Highly Selective and Potent FGFR4 Inhibitor for the Treatment of FGF19-Driven Hepatocellular Cancer

27. Supplementary Materials and Methods from FGF401, A First-In-Class Highly Selective and Potent FGFR4 Inhibitor for the Treatment of FGF19-Driven Hepatocellular Cancer

28. Supplementary Figure S4 from FGF401, A First-In-Class Highly Selective and Potent FGFR4 Inhibitor for the Treatment of FGF19-Driven Hepatocellular Cancer

29. FGF401 characterizing data from FGF401, A First-In-Class Highly Selective and Potent FGFR4 Inhibitor for the Treatment of FGF19-Driven Hepatocellular Cancer

31. Inferring and comparing metabolism across heterogeneous sets of annotated genomes using AuCoMe

32. Induction of Phlorotannins and Gene Expression in the Brown Macroalga Fucus vesiculosus in Response to the Herbivore Littorina littorea

33. Chemical Optimization of CBL0137 for Human African Trypanosomiasis Lead Drug Discovery

36. JDQ443, a Structurally Novel, Pyrazole-Based, Covalent Inhibitor of KRASG12C for the Treatment of Solid Tumors

38. A highly prevalent filamentous algal endophyte in natural populations of the sugar kelp Saccharina latissima is not detected during cultivation in Northern Brittany

40. Abstract 4026: JDQ443, a covalent inhibitor of KRASG12C with a novel binding mode, shows broad antitumor activity in KRASG12C preclinical models as a single agent and in combination with inhibitors of SHP2, MEK or CDK4/6

41. Non ! Je veux pas y aller !

42. Characterization of Redox Sensitive Brown Algal Mannitol-1-Phosphatases.

44. Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12C

45. <Research Paper>Blending Listening and Autonomous Learning: Digital Study-Portfolios (in E3 Classes)

47. Abstract P124: JDQ443, a covalent irreversible inhibitor of KRAS G12C, exhibits a novel binding mode and demonstrates potent anti-tumor activity and favorable pharmacokinetic properties in preclinical models

50. X‐ray structure and mechanism of ZgHAD, a l‐2‐haloacid dehalogenase from the marine Flavobacterium Zobellia galactanivorans.

Catalog

Books, media, physical & digital resources